John Levine, M.D., a graft-versus-host-disease expert at the Icahn School of Medicine at Mount Sinai in New York, makes a ...

CDC researchers report a rate of 7.1 per 100,000, an increase from 5.3 per 100,000 in a previous study. But improved ...

Finding a cure for inflammatory bowel disease (IBD) would mean reducing treatment waste, according to Ashwin N.

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

The latest report by Urban Institute warns that proposed Medicaid funding cuts could cost states like California, New York, ...

The survey was conducted from March 10 through April 9, when the Department of Government Efficiency was in news ...

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

For payers, claims for rare disease treatments used to be uncommon. Not now with an increasing number of new, high-priced ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.